Andrew Adams

Managing Partner at Oak HC/FT

United States

Overview

Andrew Adams is the Co-Founder & Managing Partner at Oak HC/FT, with a successful track record of investing in companies across various stages and sectors within the healthcare industry. His notable career highlights include leading investments in companies like DispatchHealth (Series E) and DTx Pharma (Series B), demonstrating his expertise in fostering growth and innovation in healthcare technology and services.

Work Experience

Oak HC/FT

Co-Founder & Managing Partner
2014 - Current
Active Investments: August Bioservices, Curana, DispatchHealth, Galileo, Infusion for Health, Marathon Health, Medical Home Network, Noom, Precision Medicine Group, Remodel Health, Reveleer, Rialtic, Trovo Health, Unified Women's Healthcare, US HealthVest, Veda Data Prior Investments: American Esoteric Laboratories (acquired by Sonic Healthcare Limited), Argus Information & Advisory Services (acquired by Verisk Analytics), Benefitfocus (NASDAQ: BNFT), CareMedic Systems (acquired by Ingenix), CLARiENT (NASDAQ: CLRT; acquired by GE Healthcare), Core Informatics (acquired by Thermo Fisher Scientific), GeneDx Holdings (NASDAQ: WGS), Health Dialog (acquired by British United Provident Association), iHealth Technologies (merged with Connolly), Independent Living Systems, LDI Integrated Pharmacy Services (acquired by Diplomat Pharmacy), Limeade (ASX: LME), Maestro Health (acquired by AXA Group), NetSpend Corporation (NASDAQ: NTSP; acquired by TSYS), PayFlex Systems (acquired by Aetna), PharMEDium Healthcare (acquired by Clayton Dubilier & Rice)

Oak HC/FT is a venture and growth equity investment firm that focuses on healthcare information services and financial service technology.

oakhcft.com